Crohn's & Colitis Foundation Executive and Leadership Team

Sharon Lungrin, the Chief Operating Officer at Crohn's & Colitis Foundation, manages the day-to-day operational execution of the organization's strategic initiatives. This executive function encompasses optimizing internal processes, ensuring efficient resource allocation, and driving operational excellence across all departments. Lungrin oversees the implementation of programs designed to support patients and advance research, aligning operational activities with the foundation's core objectives. By streamlining operations, Sharon Lungrin enhances the foundation's capacity to deliver critical services and support to individuals affected by Crohn's disease and ulcerative colitis. The Chief Operating Officer's oversight ensures that the organization functions effectively and maximizes its impact in the pursuit of cures and improved quality of life.

Stephanie Brock, the President of the Board of Directors at Crohn's & Colitis Foundation, provides high-level governance and strategic direction for the organization. This leadership position involves guiding the board's oversight of the foundation's mission, ensuring fiscal responsibility, and championing its long-term vision. Brock collaborates with executive leadership to set strategic priorities aimed at accelerating the search for cures and enhancing patient support services. The President of the Board of Directors' role is pivotal in maintaining the foundation's integrity and maximizing its societal impact across the United States. Stephanie Brock's leadership ensures the organization remains focused on its core objectives of eradicating Crohn's disease and ulcerative colitis.

Ilise Cohen, the Immediate President at Crohn's & Colitis Foundation, provides critical leadership and strategic continuity for the organization. This executive function involves guiding key initiatives and ensuring the seamless execution of the foundation's mission to find cures for Crohn's disease and ulcerative colitis. Cohen works closely with the board and executive team to advance research efforts and improve the quality of life for affected individuals. The Immediate President's focus is on driving progress and fostering collaboration across all facets of the foundation's work. Ilise Cohen's leadership ensures sustained momentum in the pursuit of groundbreaking treatments and comprehensive patient support.

Traxx Traxx, the President at Crohn's & Colitis Foundation, directs the overall strategic vision and operational framework of the organization. This leadership role is central to advancing the foundation's dual mission of finding cures for Crohn's disease and ulcerative colitis and improving patient quality of life. Traxx oversees the implementation of critical research programs and patient advocacy efforts, ensuring alignment with the foundation's core values and objectives. The President's commitment to innovation and collaboration drives progress in understanding and treating these debilitating conditions. Traxx Traxx's leadership ensures the foundation remains at the forefront of medical research and patient support.

Jeffrey Mittleman, the President of the Board of Trustees at Crohn's & Colitis Foundation, provides essential oversight and strategic guidance for the organization's governance. This executive role ensures the foundation adheres to its mission of eradicating Crohn's disease and ulcerative colitis and enhancing patient well-being. Mittleman leads the board in setting long-term objectives, fostering philanthropic support, and ensuring the responsible management of resources dedicated to research and patient services. The President of the Board of Trustees' influence is critical in maintaining the foundation's integrity and driving its impact across the nation. Jeffrey Mittleman's dedication strengthens the organization's capacity to achieve its ambitious goals.

Rohit Suri, the Chief Technology Officer at Crohn's & Colitis Foundation, directs the organization's technology strategy and infrastructure. This leadership role involves overseeing all aspects of digital transformation, ensuring robust and scalable technology solutions support the foundation's mission of finding cures and improving patient quality of life. Suri architects the technological framework that enables efficient data management, secure communication channels, and advanced research support systems. By driving innovation in technology, Rohit Suri enhances the foundation's operational capacity and its ability to connect with and support patients across the United States. The Chief Technology Officer's focus remains on leveraging cutting-edge technology to accelerate progress in research and expand the reach of patient services.

Orna Ehrlich, the Chief of Staff and Impact at Crohn's & Colitis Foundation, provides strategic support and drives the measurement of organizational impact. This critical role involves coordinating cross-functional initiatives, ensuring alignment with the foundation's mission, and enhancing the effectiveness of its programs. Ehrlich oversees the assessment of the foundation's influence on patient outcomes and research advancements, translating data into actionable insights. By focusing on impact, Orna Ehrlich ensures that all efforts contribute directly to finding cures and improving the quality of life for those affected by Crohn's disease and ulcerative colitis. The Chief of Staff and Impact's dedication to strategic execution and outcome measurement strengthens the foundation's overall effectiveness.